“The approval also provides recognition that this is a real medical disorder that can be addressed," Elkadry said.
Lynette Summerill is an award-winning writer and Scuba enthusiast who lives in San Diego with her husband and two beach loving dogs. In addition to writing about cancer-related issues for EmpowHER, her work has been seen in publications internationally.
Woodhouse, J.B., P. Patki, K. Patil, J. Shah. "Botulinum Toxin and the Overactive Bladder." Br J Hosp Med 67.9 (2006): 460-464.
Overactive Bladder. Mayo Clinic. Accessed 15 July 2013.
Kelton OAB Quarterly Index Survey, Allergan, 2013, The Overactive Bladder Survey was conducted between April 12th and April 23rd, 2013 among 1,045 nationally representative American women ages 45 and older, using an email invitation and an online survey.
Urology Care Foundation, the official foundation of the American Urological Association. Overactive Bladder Web page Accessed 15 July, 2013.
Allergan Survey: 1 in 5 Women Embarrassed to Talk About OAB:
FDA Approves OXYTROL® FOR WOMEN, the First Over-the-Counter Treatment for Overactive Bladder in Women.
Merck Press Release. 25 Jan. 2013.
Reviewed July 15, 2013
by Michele Blacksberg RN
Edited by Jody Smith